Are the CSF levels of 24S-hydroxycholesterol a sensitive biomarker for mild cognitive impairment?

Neuroscience Letters

Volumn 397, Issue 1-2, 2006, Pages 83-87

  Leoni, Valerio ^a,b   Shafaati, Marjan ^a   Salomon, Alina ^a   Kivipelto, Miia ^a   Björkhem, Ingemar ^a   Wahlund, Lars Olof ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Aging; Biomarker; Cholesterol; Dementia; Gas chromatography mass spectrometry

Indexed keywords

AMYLOID BETA PROTEIN; BIOLOGICAL MARKER; CHOLESTEROL DERIVATIVE; TAU PROTEIN;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; ARTICLE; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION COEFFICIENT; DEGENERATIVE DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MALE; NERVE CELL DEGENERATION; NERVE CELL LESION; PRIORITY JOURNAL; RANK SUM TEST; RISK FACTOR; STUDENT T TEST;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; COGNITION DISORDERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYDROXYCHOLESTEROLS; MALE; MENTAL STATUS SCHEDULE; STATISTICS; TAU PROTEINS;

EID: 33644752889     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2005.11.046     Document Type: Article

References (27)

1. N. Andreasen, C. Hesse, P. Davidsson, A. Wallin, L. Minthon, B. Winblad, H. Vanderstichele, E. Vanmechelen, and K. Blennow Cerebrospinal fluid - amyloid (1-42) in Alzheimer's disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease Arch. Neurol. 56 1999 673 680
2. A. Babiker, O. Andersson, D. Lindblom, J. van der Linden, B. Wiklund, D. Lütjohann, U. Diczfalusy, and I. Björkhem Elimination of cholesterol as cholestenoic acid in human lung by sterol 27-hydroxylase: evidence that most of this steroid in the circulation is of pulmonary origin J. Lipid Res. 40 1999 1417 1425
3. I. Björkhem, D. Lütjohann, U. Diczfalusy, L. Ståhle, G. Ahlborg, and J. Wahren Cholesterol homeoastasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterols in the circulation J. Lipid Res. 39 1998 1594 1600
4. I. Björkhem, U. Diczfalusy, and D. Lütjohann Removal of cholesterol from extrahepatic sources by oxidative mechanism Curr. Opin. Lipidol. 10 1999 161 165
5. I. Bjorkhem, and S. Meaney Brain cholesterol: long secret life behind a barrier Arterioscler. Thromb. Vasc. Biol. 24 2004 806 815
6. K. Blennow, and H. Hampel CSF markers for incipient Alzheimer's disease Lancet Neurol. 2 2003 605 613
7. K. Blennow, A. Wallin, H. Ågren, C. Spenger, J. Siegfried, and E. Vanmechelen Tau protein in cerebrospinal fluid: a biochemical diagnostic marker for axonal degeneration in Alzheimer's disease? Mol. Chem. Neuropathol. 26 1995 231 245
8. K. Blennow, A. Wallin, P. Fredman, I. Karlsson, C.G. Gottfries, and L. Svennerholm Blood brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors Acta Neurol. Scand. 81 1990 323 326
9. R.P. Cook Distribution of sterols in organism and in tissues R.P. Cook Cholesterol, Chemistry Biochemistry and Pathology 1958 Academic Press NY
10. H. Davson, and M.B. Segal Physiology of the CSF and Blood-Brain Barriers 1996 CRC Press Boca Raton, FL
11. M. Heverin, S. Meaney, D. Lütjohann, U. Diczfalusy, J. Wahren, and I. Björkhem Crossing the barrier: net flux of 27-hydroxycholesterol into the human brain J. Lipid Res. 46 2005 1047 1052
12. J.D. Huber, R.D. Egleton, and T.P. Davis Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier Trends Neurosci. 24 2001 719 725
13. B. Ibach, H. Binder, M. Dragon, S. Poljansky, E. Haen, E. Schmitz, H. Koch, A. Putzhammer, H. Kluenemann, W. Wieland, G. Hajak, Cerebrospinal fluid tau and β-Amyloid in Alzheimer disease controls and an age-matched random sample, Neurobiol. Aging, in press.
14. V. Leoni, D. Lütjohann, and T. Masterman Levels of 7-oxocholesterol in cerebrospinal fluid in patients with multiple sclerosis are more than one thousand times lower than reported J. Lipid Res. 46 2005 191 195
15. V. Leoni, T. Masterman, U. Diczfalusy, G. De Luca, J. Hillert, and I. Björkhem Changes in human plasma levels of 24S-hydroxycholesterol during progression of multiple sclerosis Neurosci. Lett. 331 2002 163 166
16. V. Leoni, T. Mastermann, F.S. Mousavi, B. Wretlind, L.O. Wahlund, U. Diczfalusy, J. Hillert, and I. Björkhem Diagnostic use of cerebral and extracerebral oxysterols Clin. Chem. Lab. Med. 42 2004 186 191
17. V. Leoni, T. Masterman, P. Patel, S. Meaney, U. Diczfalusy, and I. Björkhem Side-chain oxidised oxysterols in cerebrospinal fluid and integrity of the blood-brain barrier J. Lipid Res. 44 2003 793 799
18. E.G. Lund, J.M. Guileyardo, and D.W. Russel cDNA cloning of cholesterol 24-hydroxylase, a mediator of the cholesterol homeostasis in the brain Proc. Natl. Acad. Sci. U.S.A. 96 1999 7238 7243
19. D. Lütjohann, O. Breuer, G. Ahlborg, I. Nennesmo, Å. Siden, U. Diczfalusy, and I. Björkhem Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation Proc. Natl. Acad. Sci. U.S.A. 93 1996 9799 9804
20. D. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 34 1984 939 944
21. N.R. Saunders, M.D. Habgood, and K.M. Dziegielewska Barrier mechanism in the brain, I. Adult brain Clin. Exp. Pharm. Phys. 26 1999 11 19
22. N.R. Saunders, G.W. Knott, and K.D. Dziegielewska Barriers in the immature brain Cell. Mol. Neurobiol. 20 2000 29 39
23. M. Segal The choroid plexus and the barriers between the blood and the cerebrospinal fluid Cell. Mol. Neurobiol. 20 2000 183 196
24. M. Sjogren, H. Vandersrichle, H. Ågren, O. Zachrisson, M. Edsbagge, C. Wikkelsø, I. Skoog, A. Wallin, L.O. Wahlund, J. Marcusson, K. Nägga, N. Andreansen, P. Davidson, E. Vanmechelen, and K. Blennow Tau and Aβ42 in cerebrospinal fluid from healthy adults 21-93 years of age: estabilishment of reference values Clin. Chem. 47 2001 1776 1781
25. B.E. Tomlinson, G. Blessed, and M. Roth Observation of the brain of demented old people J. Neurol. Sci. 11 1970 205 242
26. E. Vanmechelen, H. Vanderstichele, P. Davidsson, E. van Kerschaver, B. van der Perre, M. Sjögren, N. Andreasen, and K. Blennow Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization Neurosci. Lett. 285 2000 49 52
27. D. Winblad, K. Palmer, M. Kivipelto, V. Jelic, L. Fratiglioni, L.O. Wahlund, A. Nordberg, L. Bäckman, M. Albert, O. Almkvist, H. Arai, H. Basun, K. Blennow, M. De Leon, C. Decarli, T. Erkinjutti, E. Giacobini, C. Graff, J. Hardy, C. Jack, A. Jorm, K. Ritchie, C. Van Duijn, P. Visser, and R.C. Peteresen Mild cognitive impairment - beyond controversies, towards a consensus: report of the international Working Group on Mild Cognitive Impairment J. Intern. Med. 256 2004 240 246